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WHAT THIS PAPER ADDS
This international Delphi process has generated a core set of items to be captured by vascular quality registries
that are speciﬁc for acute limb ischaemia (ALI) and supplement previous recommendations for chronic pe-
ripheral arterial occlusive disease. This core set can be used to standardise data collection for comparability
across registries and thereby facilitate amalgamation of real world data, and comparisons between centres,
regions, and countries. Ultimately, harmonised registries will provide a base for international collaboration to ﬁll
evidence gaps and contribute to improving the care of patients with ALI.
Objective: To develop a minimum core data set for evaluation of acute limb ischaemia (ALI) revascularisation
treatment and outcomes that would enable collaboration among international registries.
Methods: A modiﬁed Delphi approach was used to achieve consensus among international multidisciplinary
vascular specialists and registry members of the International Consortium of Vascular Registries (ICVR).
Variables identiﬁed in the literature or suggested by the expert panel, and variables, including deﬁnitions,
currently used in 15 countries in the ICVR, were assessed to deﬁne both a minimum core and an optimum
data set to register ALI treatment. Clinical relevance and practicability were both assessed, and consensus
was deﬁned as  80% agreement among participants.
Results: Of 40 invited experts, 37 completed a preliminary survey and 31 completed the two subsequent Delphi
rounds via internet exchange and face to face discussions. In total, 117 different items were generated from the
various registry data forms, an extensive review of the literature, and additional suggestions from the experts, for
potential inclusion in the data set. Ultimately, 35 items were recommended for inclusion in the minimum core
data set, including 23 core items important for all registries, and an additional 12 more speciﬁc items for
registries capable of capturing more detail. These 35 items supplement previous data elements recommended
for registering chronic peripheral arterial occlusive disease treatment.
Conclusion: A modiﬁed Delphi study allowed 37 international vascular registry experts to achieve a consensus
recommendation for a minimum core and an optimum data set for registries covering patients who undergo
ALI revascularisation. Continued global harmonisation of registry infrastructure and deﬁnition of items allows
international comparisons and global quality improvement. Furthermore, it can help to deﬁne and monitor
standards of care and enable international research collaboration.
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INTRODUCTION
Although more widespread antithrombotic treatment of
atrial ﬁbrillation (one of the most important causes) has led
to a decreasing incidence of acute limb ischaemia (ALI), this
limb and life threatening condition remains a great chal-
lenge for vascular surgeons and interventionists.1 Like all
emergency conditions, ALI is difﬁcult to study. To date, the
evidence base regarding open surgical vs. thrombolytic
therapy is limited to a few outdated randomised controlled
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trials.2 Thus there is a need to gather real world data on risk
factors, treatment, and outcome at the time when novel
pharmaceutical agents and interventional techniques have
entered clinical practice. Patient registries can provide
valuable contemporary data to address open questions.
However, there is no consensus among national registries
regarding which data elements are critical or how to cate-
gorise these to allow harmonisation.
International collaborations such as the International
Consortium of Vascular Registries (ICVR; www.icvr-initiative.
org) are intended to promote cross border research. The
ICVR includes countries with vascular surgery registries such
as the Vascular Quality Initiative (www.vqi.org) in the USA
and the Vascunet collaboration of vascular registries from
20 countries in Europe and Australasia (www.vascunet.
org).3,4 The ICVR was established in 2014 with the goal of
implementing a collaborative platform across registries to
share data in order to improve the quality of vascular health
care.5 Contributions regarding abdominal aortic aneu-
rysms,6 carotid artery stenosis,7 and recommendations on
chronic peripheral arterial occlusive disease (PAOD) revas-
cularisation registries were recently published by this
collaboration.8,9 In the current project, ICVR members
applied a modiﬁed Delphi approach to achieve agreement
on both a minimum core and optimum dataset for registries
capturing risk factors, treatment patterns, and outcome for
patients treated for ALI in addition to prior recommenda-
tions on chronic PAOD. The results of the current study aim
to supplement the European Society for Vascular Surgery
(ESVS) practical guidelines on ALI (to be published in 2020).
Furthermore, the results of the current study aim to amplify
prior recommendations on chronic PAOD. Registries already
collecting patients with chronic PAOD can extend their
scope by using the current recommendations.
METHODS
The Delphi approach is widely accepted and used to gain
consensus among a panel of experts,10 and has previously
been used in various specialties, including vascular medi-
cine.8,11e15 The registry data forms of all 14 registries
participating in the ICVR were reviewed to identify relevant
items for ALI needed to supplement current ICVR recom-
mendations on registration of chronic PAOD revascularisa-
tions.8 Additionally, a narrative literature review was
conducted to identify potential additional items to record
for ALI. Medline was searched for meta-analyses, systematic
reviews, and guidelines, using a combination of keywords
referring to ALI (acute limb ischaemia, acute limb ischaemia,
acute arterial occlusion, acute leg ischaemia, acute leg
ischaemia, ischaemic foot) and quality improvement mea-
surement (registry, registries, outcome, end point, follow
up, measures, performance measures, items). In addition, a
grey literature search was performed: websites concerning
ALI or indicators of outcome were searched by hand for
guidelines, statements, and quality indicators. The search
was restricted to the English language. No restriction
regarding publication date was used. All ICVR experts were
invited to evaluate the list of items identiﬁed during this
process and to suggest additional items to be included in
the Delphi process. All participants agreed to the scope of
items identiﬁed through the above mentioned process.
Members of the ICVR and members of the writing com-
mittees of the 2017 European Society of Cardiology
Guidelines on the Diagnosis and Treatment of Peripheral
Arterial Diseases, in collaboration with the ESVS,16 as well
as the ESVS guidelines on ALI (to be published in 2020),
were then invited to participate in web based, anonymised
electronic questionnaires. Open source software (Lime-
survey, Hamburg, Germany; www.limesurvey.org) was used
to generate the questionnaires and there was no further
quality control of the software by the authors. The partici-
pants could only submit one set of answers in each Delphi
round. Following the preliminary survey and ﬁrst round, a
structured report, including distribution of the group re-
sponses using bar charts, as well as comments, was for-
warded to the participants via email before they were
invited to the next round. In the ﬁrst round, each partici-
pant was asked to score each item in terms of clinical
relevance, as well as practicability in clinical practice. Each
item was scored for both parameters on a ﬁve point Likert
scale, comprising “strongly agree”, “agree”, “neutral”,
“disagree”, and “strongly disagree”. Items received a
consensus recommendation for the minimum dataset if at
least 80% of the participants voted “strongly agree” or
“agree” for clinical relevance and practicability. Items with
<60% agreement for clinical relevance or practicability
were eliminated from further consideration. In line with
prior recommendations,8 a set of minimum core data ele-
ments felt necessary for any registry (level 1) were deﬁned,
as well as an optimum set of additional data elements (level
2) recommended for registries capable of collecting more
detailed information. In general, level 1 variables typically
had simple options (e.g., yes, no), while level 2 variables
had increasing speciﬁcity. For example, only a history of a
peripheral aneurysm was recommended for level 1, while
the speciﬁc location and diameter of a peripheral aneurysm
were recommended for level 2 reporting (see Table 1).
Level 1 data elements were judged sufﬁciently important to
always be registered. The median time for the experts to
answer a question in the modiﬁed Delphi process (duration
between opening the questionnaire and saving the results)
is displayed as median time in minutes, including inter-
quartile range (IQR).
Statistical analysis
The agreement of individual experts’ answers in both Delphi
rounds was tested using the Student t test and mean dif-
ference for the tendency of answering. Missing data due to
non-participation in one round were not imputed. Statistical
analyses were performed with software R version 3.3.2 (The
R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Of 40 experts invited, 37 (93%) accepted and completed the
preliminary survey. The panel comprised vascular surgeons
Recommendations for Registry Data Collection for Acute Limb Ischaemia Management 817
Table 1. Thirty-ﬁve items in ﬁve categories (risk factors, medication, clinical presentation, procedure details, outcome) to be
recommended for acute limb ischaemia revascularisation registries
Item Level 1 Level 2/3
Risk factors
History of malignancy Yes/no If yes: type of malignancy, type of
treatment
History of atrial ﬁbrillation or
atrial ﬂutter
Yes/no If yes: paroxysmal vs. permanent
History of arterial embolisation Yes/no
History of peripheral aneurysm Yes/no If yes: location and diameter of
peripheral aneurysm
History of stroke Yes/no




reconstruction of affected leg
Yes/no Type of prior revascularisation/
reconstruction; if any: prior
catheter based intervention
Medication
If any: type of anticoagulants at
presentation
For example, vitamin K
antagonists, direct oral
anticoagulants, heparin
If any: name and dose of
anticoagulants




Rutherford ischaemia classes I, IIA, IIB, III
Sensory deﬁcit Yes/no
Motor deﬁcit Yes/no
Upper vs. lower extremity Arm/leg/both
Aetiology or cause of acute limb
ischaemia
/ Native artery thrombosis,
embolus, acute native artery






Concomitant embolic focus / Coronary arteries, carotid or
vertebral arteries, visceral
arteries, renal arteries, other
Level/location of index
occlusion
/ Upper/lower arm, aorto-iliac/
above the knee/below the knee
Procedure
Ischaemia duration: time from
ﬁrst symptom to procedure







Multiple selection: best medical
treatment only, primary









Rutherford ischaemia classes / I, IIA, IIB, III
Residual sensory deﬁcit / Yes/no
Residual motor deﬁcit / Yes/no
Compartment syndrome Yes/no If compartment syndrome:
unplanned fasciotomy




Haemorrhage at access site / Yes/no
Infection at (surgical) access site / Yes/no
Acute kidney injury Yes/no
Multi-organ failure / Yes/no
If death: cause of death / Death related to acute limb
ischaemia?
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and interventionists (both internal medicine specialists and
radiologists), representing 15 countries and 36 institutions.
In total, 76 items potentially useful to register ALI treatment
were identiﬁed from the available literature, while another
79 items were already recommended for chronic PAOD in a
prior study and, accordingly, excluded from this evaluation.
Additionally, 41 complementary items were suggested by
the expert panel during the preliminary survey. Ultimately,
117 items were included in the panel discussion (Table S1;
see Supplementary Material). The ﬁnal number of data el-
ements was not deﬁned prior to the Delphi rounds. The
items were reviewed by the authors, and subsequently
sorted into ﬁve main categories: risk factors, medication,
clinical presentation, procedure details, and outcome.
Thirty-seven panel experts completed round 1 (median
22.6 min, IQR 18.0) and 31 of them also completed round 2
(median 7.7 min, IQR 3.7).
After the ﬁrst Delphi round, 37 items reached the 80%
consensus limit for clinical relevance. Of these, 23 items
also reached the 80% consensus limit for practicability
(excellent level of agreement) (Fig. 1) and one item failed to
reach the 60% limit for practicability. Another 61 items
failed to reach the 60% limit for clinical relevance. After a
group discussion, 33 items were recommended after the
ﬁrst Delphi round and an additional 23 items with ambig-
uous results (between 60% and 80% limit of agreement)
were forwarded to the second Delphi round.
After two Delphi rounds, two of 23 items with ambiguous
results (from round 1) reached the 80% consensus limit for
clinical relevance and practicability: “aetiology or cause of
ALI” and “time from the ﬁrst symptom to procedure”
reached at least 80% consensus for clinical relevance and
practicability. The remaining 21 items included into the
second Delphi round failed to reach the 80% limit of
agreement.
The Delphi process (Fig. 1) ultimately recommended 35
items (33 items from Delphi round 1 and two items from
Delphi round 2) speciﬁc to ALI treatment for registry
collection (with different levels of potential detail)
(Table 1). It was also recommended that all registries create
the response alternative “unknown”, in order to differen-
tiate omitted from unknown data, and not force users to
choose an unclear option. However for simplicity, the
“unknown” options for each variable have not been
included in Table 1.
DISCUSSION
In this modiﬁed Delphi study involving 37 international
experts in multidisciplinary vascular care and registry based
research, consensus to recommend 35 additional items
speciﬁc to ALI treatment for registries was achieved. These
items, speciﬁc for ALI, supplement prior recommendations
on registering patients treated for chronic PAOD (79 items),
and will help to harmonise international research using real
world data.8,17 It must be noted that in order to beneﬁt
from the current recommendations, registries should cap-
ture selected items of interest for ALI from prior
recommendations on chronic PAOD. Important risk factors
and outcomes such as amputations have not been included
in the current ALI Delphi process but were already captured
by prior recommendations.
Patients with ALI are known to be elderly, and they
frequently suffer from multiple comorbidities. Of 45
different risk factors evaluated in this Delphi study, the
expert panel selected seven items to supplement the min-
imum data set recommended for chronic PAOD. Interest-
ingly, > 10 different laboratory values were considered by
the expert panel, but none reached the 60% consensus limit
during the two Delphi rounds. As for medication, only
treatment with any anticoagulation reached level 1. For
example, the use of heparin in the emergency department
was not included, despite the fact that this practice is
associated with reduced risk of death and amputation.18,19
The aetiology of ALI was considered clinically relevant but
not practicable in >80%, and therefore set as a level 2
recommendation, owing to difﬁculty distinguishing be-
tween a non-classical embolism and thrombosis.
Despite changing environments and the widespread
adoption of endovascular techniques, the treatment of this
urgent condition in daily practice remains challenging. High
amputation and mortality rates remain important conse-
quences of ALI, emphasising the need for further research
to improve and harmonise care.20e23 To this end, treatment
practices were included as an important component of this
study. Ischaemic duration reached a high level of consensus
and is a key factor for outcome, but to the authors’
knowledge, is not yet included in any registry for ALI. This
new indicator may help to reduce time delay and can be
used for future quality improvement projects.
To ameliorate this situation and to reach consensus on
the treatment of ALI, the ESVS has initiated a process of
developing clinical practice guidelines for the treatment of
ALI, to be published in early 2020.
This study has limitations. Firstly, the composition of the
expert panel may have signiﬁcantly affected the group
discussion and subsequent consensus. As patients with ALI
are treated by different medical specialties, there might be
disagreement among the panel members on how to treat
these patients which could affect the evaluation of items. To
address this bias, the panel comprised experts from all
medical specialties involving vascular surgery, internists,
and radiology. Secondly, the point of including the patient’s
point of view is essential in modern patient centred medi-
cine. According to that, items considering patient reported
outcome measures (e.g., quality of life) were included in the
Delphi process but failed to reach the required consensus
limit (62% for clinical relevance, but only 38% for practica-
bility in current registries). This result may be explained by
the perceived difﬁculty, right or wrong, of involving patients
who are frail and suffering an acute life threatening con-
dition, in the decision making. Lastly, the recommendations
of the current study can only reﬂect the group consensus
among countries participating in the Delphi process. The
VASCUNET collaboration and the ICVR should raise their
efforts to involve more countries in the future.
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Registry based quality improvement projects should in
the future result in the collection of self reported patient
data after treatment for emergency diseases such as ALI.
This would also decrease the rapidly growing documenta-
tion burden and improve the practicability of quality
improvement registries. There are a number of ways to
integrate patient related outcome data into registries. The
development of electronic health technology is a rapidly
evolving ﬁeld with easy to use applications that appears to
enhance patient care.24
CONCLUSIONS
This modiﬁed Delphi study among international vascular
registry specialists achieved consensus on a minimum core
and optimum dataset for registries evaluating ALI
76 items
identified in the literature
41 Items 
suggested by the expert panel
117 Items 
included in the panel evalution
33 Items
recommended after 1st round
23 Items
recommended after 2 nd round
23 Items 
included in the 2nd round
61 Items 
not recommended after  1st round
Risk Factors
History of malignancy
History of atrial fibrillation or flutter
History of atrial embollation 
History of peripheral aneurysm
History of stroke
History of aortic aneurysm
Type of prior reconstruction/revasc.
Type of anticoagulants
Any recent change of anticoagulants
Upper versus lower extremities
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not recommended after  2 nd round
23 Items 
reached excellent agreement
Figure 1. Flow chart of the modiﬁed Delphi expert consensus process. Of 117 items included in the panel evaluation, a total of 35 registry
items were recommended for acute limb ischaemia revascularisation registries. The red bars illustrate the group results for clinical relevance.
The blue bars represent the group results for practicability. Twenty-three items reached excellent levels of agreement for both clinical
relevance and practicability (star).
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revascularisation. It reduced the overall number of initial
potential variables by nearly half. This core set of items has
the potential to standardise data collection between exist-
ing and upcoming registries so that clinical data on ALI
revascularisation can be merged and compared.
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